Sales of cardiovascular products rose 15.9% in the quarter, helping Boston Scientific beat estimates.
Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance
![](https://themarketcrash.net/wp-content/uploads/2022/06/imgpsh_fullsize_anim-6-800x400.png)
Sales of cardiovascular products rose 15.9% in the quarter, helping Boston Scientific beat estimates.
Comments